NEWS
You can follow the latest news of MicroViable in this section
GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
Microviable Therapeutics appoints Luis Gosálbez as a member of its Business Advisory Board
Microviable Therapeutics announced the appointment of Dr. Luis Gosálbez as a member of its Business Advisory Board. Gosálbez brings 10 years of experience in business strategy and corporate development for life sciences companies specialized in [...]
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. Claudio Hidalgo, CEO at Microviable, Noelia Martínez, R&D Director, and Ignacio [...]
Microviable will be attending the XIV Workshop of the SEMiPyP
Microviable Therapeutics will be attending the XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. The event will make special mention of the new advances in [...]
Microviable Therapeutics welcomes our internship student José González
Microviable welcomes to the team our new internship student José González Poyo, Master in Environmental and Health Biotechnology from the University of Oviedo.
Microviable Therapeutics is looking for a bioinformatician
We are looking for a full-time, highly motivated individual to work as a bioinformatician in our team to develop prediction models using artificial intelligence for novel biotherapeutics development. More information If you are interested [...]